XML 25 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2019
Mar. 31, 2019
ASSETS    
Cash and cash equivalents $ 4,832 $ 2,198
Restricted cash and cash equivalents 940 985
Investments in marketable securities 3,627 2,908
Finance receivables, net 73,450 70,517
Investments in operating leases, net 37,403 37,927
Other assets 2,355 1,981
Total assets 122,607 116,516
LIABILITIES AND SHAREHOLDER’S EQUITY    
Debt 97,534 92,922
Deferred income taxes 5,656 5,452
Other liabilities 4,828 4,564
Total liabilities 108,018 102,938
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:    
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at December 31, 2019 and March 31, 2019 915 915
Additional paid-in capital 2 2
Accumulated other comprehensive income 15 3
Retained earnings 13,657 12,658
Total shareholder's equity 14,589 13,578
Total liabilities and shareholder's equity $ 122,607 $ 116,516